GB9509844D0 - Screening for inhibitors of TCR-MHC interactions - Google Patents
Screening for inhibitors of TCR-MHC interactionsInfo
- Publication number
- GB9509844D0 GB9509844D0 GBGB9509844.8A GB9509844A GB9509844D0 GB 9509844 D0 GB9509844 D0 GB 9509844D0 GB 9509844 A GB9509844 A GB 9509844A GB 9509844 D0 GB9509844 D0 GB 9509844D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tcr
- inhibitors
- screening
- mhc interactions
- mhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509844.8A GB9509844D0 (en) | 1995-05-16 | 1995-05-16 | Screening for inhibitors of TCR-MHC interactions |
AU57690/96A AU5769096A (en) | 1995-05-16 | 1996-05-16 | Screening for inhibitors of tcr-mhc interactions |
PCT/GB1996/001165 WO1996036881A2 (en) | 1995-05-16 | 1996-05-16 | Screening for inhibitors of tcr-mhc interactions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509844.8A GB9509844D0 (en) | 1995-05-16 | 1995-05-16 | Screening for inhibitors of TCR-MHC interactions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9509844D0 true GB9509844D0 (en) | 1995-07-12 |
Family
ID=10774510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9509844.8A Pending GB9509844D0 (en) | 1995-05-16 | 1995-05-16 | Screening for inhibitors of TCR-MHC interactions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5769096A (en) |
GB (1) | GB9509844D0 (en) |
WO (1) | WO1996036881A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031625A1 (en) | 1995-04-07 | 1996-10-10 | Cytogen Corporation | Polypeptides having a functional domain of interest and methods of identifying and using same |
US6309820B1 (en) | 1995-04-07 | 2001-10-30 | University Of North Carolina At Chapel Hill | Polypeptides having a functional domain of interest and methods of identifying and using same |
WO1997044667A2 (en) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
AU2481399A (en) * | 1998-01-29 | 1999-08-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Variant peptide ligands that selectively induce apoptosis |
WO2001090747A2 (en) * | 2000-05-25 | 2001-11-29 | Sunol Molecular Corporation | Modulation of t-cell receptor interactions |
US20210371849A1 (en) * | 2018-07-31 | 2021-12-02 | Janux Therapeutics, Inc. | Inhibitory t cell receptor peptides and discovery methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU669329B2 (en) * | 1991-03-22 | 1996-06-06 | Trustees Of The University Of Pennsylvania, The | Method of modulating mammalian T-cell response |
CN1135181A (en) * | 1993-09-14 | 1996-11-06 | Cytel有限公司 | Alteration of immune response using pan Dr-binding peptides |
-
1995
- 1995-05-16 GB GBGB9509844.8A patent/GB9509844D0/en active Pending
-
1996
- 1996-05-16 AU AU57690/96A patent/AU5769096A/en not_active Abandoned
- 1996-05-16 WO PCT/GB1996/001165 patent/WO1996036881A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996036881A2 (en) | 1996-11-21 |
WO1996036881A3 (en) | 1997-01-09 |
AU5769096A (en) | 1996-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL327569A1 (en) | Promedications of thrombosin inhibitors | |
IL122266A0 (en) | Inhibitors of phospholipase A2 | |
EP0794789A4 (en) | Inhibitors of prenyl transferases | |
AU8256098A (en) | Systems and methods for parallel synthesis of compounds | |
PL324527A1 (en) | Cyclic inhibitors of gmp-specific phosphodisterase | |
EP0835109A4 (en) | Pyridinone-thrombin inhibitors | |
PL321759A1 (en) | Novel thrombosin inhibitors | |
IL118101A0 (en) | Inhibitors of farnesyltransferase | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
EP0769065A4 (en) | Methods for identifying inhibitors of integrin activation | |
HUP9900110A3 (en) | Novel process for the synthesis of omeprazole | |
AU8245898A (en) | Apparatus for sanitary packing of used objects | |
PL321659A1 (en) | Bidged indoles as inhibitors of matrix metaloproteases | |
AU6692996A (en) | Inhibitors of apoptosis | |
AU6904596A (en) | Method and construct for screening for inhibitors of transcriptional activation | |
ZA9610798B (en) | Inhibitors of interleuken-1beta converting enzyme | |
AU5512096A (en) | Method of inhibiting restenosis using calreticulin | |
GB9509844D0 (en) | Screening for inhibitors of TCR-MHC interactions | |
IL124871A0 (en) | Naphthyl glyoxamides as spla2 inhibitors | |
GB9701245D0 (en) | Method of screening compounds | |
GB9502985D0 (en) | Enzyme inhibitors | |
IL113228A0 (en) | Derivatives of anandamide | |
IL123507A (en) | Set of structural elements for constructions | |
GB9421118D0 (en) | Method of screening for CD31 interaction inhibitors | |
PL322822A1 (en) | Method of obtaining streptogramins |